Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 12/20 | 0.57 |
| ▸ | TLR8 | Q9NR97 | 4/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 2/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13663010 | 0.89 | TLR7 (0.46) | TLR7TLR8ALOX15HTTGLO1 | |
| SCHEMBL4301043 | 0.79 | TLR7 (0.47) | TLR7TLR8 | |
| SCHEMBL13431440 | 0.78 | TLR7 (0.55) | TLR7TLR8 | |
| SCHEMBL13652673 | 0.78 | TLR7 (0.63) | TLR7TLR8ALOX15HTTGLO1 | |
| SCHEMBL30346065 | 0.77 | TLR7 (0.61) | TLR7TLR8 | |
| SCHEMBL4155959 | 0.77 | TLR7 (0.61) | TLR7TLR8HRH1KCNH2 | |
| SCHEMBL483291 | 0.77 | TLR7 (0.61) | TLR7TLR8 | |
| SCHEMBL4152641 | 0.77 | TLR7 (0.53) | TLR7TLR8ALOX15HTTGLO1 | |
| SCHEMBL4151486 | 0.75 | TLR7 (0.52) | TLR7TLR8ALOX15HTTGLO1 | |
| SCHEMBL4147486 | 0.75 | TLR7 (0.52) | TLR7TLR8ALOX15HTTGLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090270443-A1 | 1-AMINO IMIDAZO-CONTAINING COMPOUNDS AND METHODS | COLEY PHARMACEUTICAL GROUP, INC. | 2009-10-29 | — | — | US | disclosed |
| WO-2006026760-A2 | 1-AMINO IMIDAZO-CONTAINING COMPOUNDS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270443-A1 | 1-AMINO IMIDAZO-CONTAINING COMPOUNDS AND METHODS | IL2, IL4I1, IFNG | TLR7 188/4885TLR8 208/4885ALOX15 3865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.